Provider P23-18 Clinical Reviews for Court-Ordered Substance Use Disorder Treatment - Opens in a new window Read More - Opens in a new window
Provider P2R1-18 Updated: New Medical Drug Prior Authorization Requirements for Voretigene Neparvovec (Luxturna) - Opens in a new window Read More - Opens in a new window
Provider P34-18 Clarification to MAPD PA Requirements for Hereditary Angioedema (HAE) Medical Drugs - Opens in a new window Read More - Opens in a new window
Provider P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018 - Opens in a new window Read More - Opens in a new window
Provider P32-18 New Requirements for Medicare and Medicaid Providers - Opens in a new window Read More - Opens in a new window
Provider P31-18 New Medical, Medical Drug and Behavioral Health Policy Management Updates for Commercial Lines of Business - Effective September 3, 2018 - Opens in a new window Read More - Opens in a new window
Provider P35-18 Update: Change to TPA Business - Opens in a new window Read More - Opens in a new window
Provider P11-18 Minnesota Health Care Programs (MHCP) Reimbursement Rate for Vaccine Administration - Opens in a new window Read More - Opens in a new window
Provider P28-18 Change to Administration of Interpreter Services for MHCP Subscribers - Opens in a new window Read More - Opens in a new window
